Skip to Content

Month: January 2022

Moderna begins next phase of Omicron-specific booster trial as study finds that antibodies remain durable despite 6-fold drop over 6 months

By Jen Christensen, CNN Moderna announced Wednesday that the first participant has been dosed in the company’s Phase 2 clinical trial of a coronavirus vaccine booster shot that is specific to the Omicron variant. Moderna is advancing the trial into its next phase as research published Wednesday in the New England Journal of Medicine found

Continue Reading